← All stocks

TENAX THERAPEUTICS, INC.

TENX Net buying
CIK 0000034956 #4570 in the set updated 21 Sep 2026
Bought (1 mo)
$3.31M
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$3.31M
+$3.31M against sales at will

By person

7 insiders · 9 transactions
0.0×

Christopher T. Giordano holds only 0.0 times base salary in stock. $42.57K of shares against $563.73K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher T. Giordano last reported holding, valued at $1.92, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ADAR1 Capital Management, LLC entity
10% owner
$3.17M (5)
+$3.17M
11,377,969
$21.85M
+31.1%
Doogan Declan
Director
$101.76K (1)
+$101.76K
55,274
$106.13K
+2,331%
Giordano Christopher Thomas
CEO
$20.09K (2)
+$20.09K
22,174
$42.57K
STAAB THOMAS R II
Chief Financial Officer
$10.98K (1)
+$10.98K
15,675
$30.10K
Rich Stuart
Chief Medical Officer
10,266
$19.71K
+3,759%
MCGAULEY THOMAS
Interim CFO
7,000
$13.44K
Almenoff June Sherie
Director
1,993
$3.83K

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 3,408,906 to 37,423,917 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 20 Oct 2016